ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T) JPX

2,408.00

-16(-0.66%)

Updated at September 12 03:30PM

Currency In JPY

ASKA Pharmaceutical Holdings Co.,Ltd.

Address

5-1, Shibaura 2-Chome

Tokyo, 108-8532

Japan

Phone

81 3 5484 8845

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

762

First IPO Date

April 01, 2021

Key Executives

NameTitlePayYear Born
Fumiyoshi YamaguchiManaging Executive Officer & Director01986
Sohta YamaguchiSenior Managing Director & Representative Director01983
Mr. Atsushi MaruoSenior Managing Director & Representative Director01959
Maiko MoriManaging Executive Officer & Director01964
Tomoyuki HatakeyamaDirector of Finance & Accounting Dept., Group Bus. Mgmt Div. and Manager of Accounting Section0N/A
Mr. Takashi YamaguchiChairman & President01952
Kiyohiko TamuraExecutive Corporate Officer & Director of Group Business Management Division0N/A

Description

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and manufactures, sells, imports, and exports veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.